After cutting back on Vuity last fall, AbbVie culls a second-gen presbyopia eye drop
In 2021, AbbVie secured the first FDA approval for an eye drop for presbyopia, but in 2022 the drugmaker reduced sales and marketing on the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
